- Home
- LEGN vs ENSG Comparison
LEGN vs ENSG Comparison
Compare LEGN & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- ENSG
- Stock Information
- Founded
- LEGN 2014
- ENSG 1999
- Country
- LEGN United States
- ENSG United States
- Employees
- LEGN N/A
- ENSG N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- ENSG Hospital/Nursing Management
- Sector
- LEGN Health Care
- ENSG Health Care
- Exchange
- LEGN Nasdaq
- ENSG Nasdaq
- Market Cap
- LEGN 7.0B
- ENSG 7.3B
- IPO Year
- LEGN 2020
- ENSG 2007
- Fundamental
- Price
- LEGN $27.78
- ENSG $149.75
- Analyst Decision
- LEGN Strong Buy
- ENSG Buy
- Analyst Count
- LEGN 13
- ENSG 7
- Target Price
- LEGN $75.67
- ENSG $164.71
- AVG Volume (30 Days)
- LEGN 1.5M
- ENSG 444.0K
- Earning Date
- LEGN 05-13-2025
- ENSG 04-29-2025
- Dividend Yield
- LEGN N/A
- ENSG 0.17%
- EPS Growth
- LEGN N/A
- ENSG 39.72
- EPS
- LEGN N/A
- ENSG 5.30
- Revenue
- LEGN $728,303,000.00
- ENSG $4,423,354,000.00
- Revenue This Year
- LEGN $65.96
- ENSG $17.71
- Revenue Next Year
- LEGN $52.55
- ENSG $9.69
- P/E Ratio
- LEGN N/A
- ENSG $28.22
- Revenue Growth
- LEGN 112.46
- ENSG 14.81
- 52 Week Low
- LEGN $29.27
- ENSG $115.79
- 52 Week High
- LEGN $60.87
- ENSG $158.45
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- ENSG 78.91
- Support Level
- LEGN $30.25
- ENSG $129.91
- Resistance Level
- LEGN $33.30
- ENSG $133.08
- Average True Range (ATR)
- LEGN 1.78
- ENSG 3.73
- MACD
- LEGN -0.57
- ENSG 1.99
- Stochastic Oscillator
- LEGN 5.19
- ENSG 98.79
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.